REGENERON PHARMACEUTICALS, INC. (REGN)
Nasdaq: REGN · CIK 0000872589 · United States
Every official REGENERON PHARMACEUTICALS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open REGN filings
REGENERON PHARMACEUTICALS, INC. documents
- REGENERON PHARMACEUTICALS, INC. 10-K 2026REGN 10-K 2026: annual report for fiscal 2026
- REGENERON PHARMACEUTICALS, INC. 10-K 2025REGN 10-K 2025: annual report for fiscal 2025
- REGENERON PHARMACEUTICALS, INC. 10-K 2024REGN 10-K 2024: annual report for fiscal 2024
- REGENERON PHARMACEUTICALS, INC. 10-K 2023REGN 10-K 2023: annual report for fiscal 2023
- REGENERON PHARMACEUTICALS, INC. 10-K 2022REGN 10-K 2022: annual report for fiscal 2022
- REGENERON PHARMACEUTICALS, INC. 10-Q 2026REGN 10-Q 2026: quarterly report for fiscal 2026
- REGENERON PHARMACEUTICALS, INC. 10-Q 2025REGN 10-Q 2025: quarterly report for fiscal 2025
- REGENERON PHARMACEUTICALS, INC. 10-Q 2024REGN 10-Q 2024: quarterly report for fiscal 2024
- REGENERON PHARMACEUTICALS, INC. 10-Q 2023REGN 10-Q 2023: quarterly report for fiscal 2023
- REGENERON PHARMACEUTICALS, INC. 10-Q 2022REGN 10-Q 2022: quarterly report for fiscal 2022
- REGENERON PHARMACEUTICALS, INC. 8-K 2026REGN 8-K 2026: current report for fiscal 2026
- REGENERON PHARMACEUTICALS, INC. 8-K 2025REGN 8-K 2025: current report for fiscal 2025
- REGENERON PHARMACEUTICALS, INC. 8-K 2024REGN 8-K 2024: current report for fiscal 2024
- REGENERON PHARMACEUTICALS, INC. 8-K 2023REGN 8-K 2023: current report for fiscal 2023
- REGENERON PHARMACEUTICALS, INC. 8-K 2022REGN 8-K 2022: current report for fiscal 2022
- REGENERON PHARMACEUTICALS, INC. DEF 14A 2026REGN DEF 14A 2026: proxy statement for fiscal 2026
- REGENERON PHARMACEUTICALS, INC. DEF 14A 2025REGN DEF 14A 2025: proxy statement for fiscal 2025
- REGENERON PHARMACEUTICALS, INC. DEF 14A 2024REGN DEF 14A 2024: proxy statement for fiscal 2024
- REGENERON PHARMACEUTICALS, INC. DEF 14A 2023REGN DEF 14A 2023: proxy statement for fiscal 2023
- REGENERON PHARMACEUTICALS, INC. DEF 14A 2022REGN DEF 14A 2022: proxy statement for fiscal 2022
- REGENERON PHARMACEUTICALS, INC. Form 4 2026REGN Form 4 2026: insider trading filing for fiscal 2026
- REGENERON PHARMACEUTICALS, INC. Form 4 2025REGN Form 4 2025: insider trading filing for fiscal 2025
- REGENERON PHARMACEUTICALS, INC. Form 4 2024REGN Form 4 2024: insider trading filing for fiscal 2024
- REGENERON PHARMACEUTICALS, INC. Form 4 2023REGN Form 4 2023: insider trading filing for fiscal 2023
- REGENERON PHARMACEUTICALS, INC. Form 4 2022REGN Form 4 2022: insider trading filing for fiscal 2022
- REGENERON PHARMACEUTICALS, INC. S-1 2026REGN S-1 2026: registration statement for fiscal 2026
- REGENERON PHARMACEUTICALS, INC. S-1 2025REGN S-1 2025: registration statement for fiscal 2025
- REGENERON PHARMACEUTICALS, INC. S-1 2024REGN S-1 2024: registration statement for fiscal 2024
- REGENERON PHARMACEUTICALS, INC. S-1 2023REGN S-1 2023: registration statement for fiscal 2023
- REGENERON PHARMACEUTICALS, INC. S-1 2022REGN S-1 2022: registration statement for fiscal 2022
- REGENERON PHARMACEUTICALS, INC. 13F 2026REGN 13F 2026: institutional holdings for fiscal 2026
- REGENERON PHARMACEUTICALS, INC. 13F 2025REGN 13F 2025: institutional holdings for fiscal 2025
- REGENERON PHARMACEUTICALS, INC. 13F 2024REGN 13F 2024: institutional holdings for fiscal 2024
- REGENERON PHARMACEUTICALS, INC. 13F 2023REGN 13F 2023: institutional holdings for fiscal 2023
- REGENERON PHARMACEUTICALS, INC. 13F 2022REGN 13F 2022: institutional holdings for fiscal 2022
More companies